Indication
Liver Carcinoma
2 clinical trials
5 products
1 drug
Clinical trial
A Phase 1b Trial of the IRX-2 Regimen and Nivolumab in Patients With Advanced Hepatocellular Cancer (HCC)Status: Active (not recruiting), Estimated PCD: 2024-12-15
Drug
cyclophosphamideProduct
IRX-2Product
NivolumabClinical trial
A Phase II Study of Pembrolizumab (MK-3475) in Hepatitis C Virus Positive and Negative Subjects With Advanced Hepatocellular Carcinoma Who Progressed on or Were Intolerant to First-Line Systemic TherapyStatus: Completed, Estimated PCD: 2023-08-09
Product
Elbasvir/GrazoprevirProduct
PembrolizumabProduct
Ribavirin